3-deazaneplanocin has been researched along with Cancer of Prostate in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawamoto, T; Tanaka, Y; Uchiyama, N | 1 |
| Lee, PL; Lee, ST; Li, Z; Lim, YP; Wee, ZN; Yu, Q | 1 |
| Carmona, FJ; Esteller, M; Fernandez, AF; Imai, K; Jacinto, FV; Marquez, VE; Puertas, S; Shinomura, Y; Taniguchi, H; Villanueva, A; Yamamoto, H | 1 |
| Kim, JH; Shin, YJ | 1 |
4 other study(ies) available for 3-deazaneplanocin and Cancer of Prostate
| Article | Year |
|---|---|
Aristeromycin and DZNeP cause growth inhibition of prostate cancer via induction of mir-26a.
Topics: Adenosine; Adenosylhomocysteinase; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Male; MicroRNAs; Prostatic Neoplasms; RNA, Small Interfering; Transcriptional Activation | 2017 |
EZH2-mediated inactivation of IFN-γ-JAK-STAT1 signaling is an effective therapeutic target in MYC-driven prostate cancer.
Topics: Adenosine; Animals; Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Humans; Interferon gamma Receptor; Interferon-gamma; Janus Kinases; Male; Mice; Mice, Nude; Polycomb Repressive Complex 2; Prostatic Neoplasms; Proto-Oncogene Proteins c-myc; Receptors, Interferon; Signal Transduction; STAT1 Transcription Factor | 2014 |
Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer.
Topics: Adenosine; Animals; Breast Neoplasms; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Female; Humans; Kruppel-Like Transcription Factors; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Polycomb Repressive Complex 2; Prostatic Neoplasms; RNA Interference; Transcription Factors; Transfection | 2012 |
The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells.
Topics: Adenosine; Blotting, Western; Cell Line, Tumor; Cell Movement; DNA-Binding Proteins; Down-Regulation; Enhancer of Zeste Homolog 2 Protein; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Matrix Metalloproteinase 9; Neoplasm Invasiveness; Neoplasm Metastasis; Polycomb Repressive Complex 2; Prostatic Neoplasms; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Tissue Inhibitor of Metalloproteinase-2; Tissue Inhibitor of Metalloproteinase-3; Transcription Factors | 2012 |